(Q43256110)

17 November 2017

0 references

Changing beta-blockers in heart failure: when is a class not a class? (English)

1 reference

17 November 2017

1

Jeffrey K Aronson

1 reference

17 November 2017

1 June 2008

1 reference

British Journal of General Practice

17 November 2017

1 reference

17 November 2017

58

1 reference

17 November 2017

551

1 reference

17 November 2017

387-389

1 reference

Identification and guided treatment of ventricular dysfunction in general practice using blood B-type natriuretic peptide.

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

The vasodilatory beta-blockers

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Nebivolol: new therapy update

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Inhibition of endothelin-1 and KCL-induced increase of [CA2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Clinical relevance of pharmacokinetic differences between beta blockers

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

The xamoterol experience in the treatment of heart failure

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Beta-blockers and sleep: a controlled trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Comparative properties of various beta-blockers, with an outlook to the future

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418988

Vasodilatory mechanism of levobunolol on vascular smooth muscle cells

25 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18505613

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18505613

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3399/BJGP08X299317

1 reference

17 November 2017

1 reference

17 November 2017

1 reference

PMCID

2418988